BICYCLE THERAPEUTICS PLC — Director's Dealing 2020

Apr 16, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BICYCLE THERAPEUTICS plc (BCYC)
CIK: 0001761612
Period of Report: 2020-04-14

Reporting Person: Winter Gregory Paul (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-14	Ordinary Shares	M	71450	—	Acquired	163927	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-04-14	Series A Preferred Shares Warrant	$	M	71450	Disposed		Ordinary Shares (71450)	Direct

Footnotes

F1: The Warrants to purchase Series A Preferred Shares had an exercise price of a nominal value per Series A Preferred Share, and, following Bicycle Therapeutics plc's initial public offering, became exercisable for ordinary shares. The Warrants are immediately exercisable and expire on May 26, 2027.